Paget's disease of bone.

Area of Science:

• Bone biology and skeletal disorders.
• Genetics and molecular mechanisms of bone diseases.

Background:

• Paget's disease of bone involves abnormal bone remodeling and osteoclast dysfunction.
• The disease's prevalence has declined, but its cause remains largely unknown.
• Genetic factors, such as p62-sequestosome gene mutations, are implicated in pathogenesis.

Purpose of the Study:

• To review current understanding of Paget's disease of bone.
• To highlight recent genetic discoveries and their implications.
• To discuss disease manifestations, complications, and treatment strategies.

Main Methods:

• Literature review of Paget's disease of bone.
• Analysis of genetic studies identifying key mutations.
• Synthesis of information on clinical presentation and therapeutic outcomes.

Main Results:

• Paget's disease is characterized by disordered bone remodeling and osteoclast abnormalities.
• Genetic studies point to mutations in the p62-sequestosome gene.
• Bisphosphonates are effective first-line treatments for symptom and disease activity reduction.

Conclusions:

• Paget's disease of bone involves complex genetic and cellular mechanisms.
• Effective treatments like bisphosphonates manage symptoms and aim to prevent complications.
• Further research is needed to fully elucidate the disease etiology and optimize management.